weight loss difference between semaglutide and tirzepatide isn't one-size-fits-all. Both are powerful tools, but they work a little differently. One may offer steady, proven progress. The other may provide stronger appetite control and greater Navigating Medical Weight Loss Solutions:

[6] Treating cagrilintide and tirzepatide as the same kind of drug misreads the biology: they touch appetite from different directions, and neither pathway makes one a substitute for the other

Those who may warrant closer monitoring include: Individuals with pre-existing tachycardia or arrhythmias, such as atrial fibrillation or supraventricular tachycardia Patients with hyperthyroidism, which independently elevates resting heart rate Those taking other medicines that may increase heart rate, including sympathomimetics (such as decongestants and stimulants), serotoninnoradrenaline reuptake inhibitors (SNRIs), tricyclic antidepressants, or beta-2 agonists used in asthma management Individuals with a history of heart failure, where even modest increases in heart rate may affect cardiac output and symptom burden though it should be noted that increased cardiovascular risk in this group is based on clinical prudence rather than confirmed harm with GLP-1 receptor agonists Patients receiving higher doses of retatrutide, given the dose-dependent nature of the effect observed in Phase 2 trials Age and baseline cardiovascular health are also relevant considerations

Treating obesity and/or diabetes, therefore, can reduce the effects of PCOS

Each week the mother of two injects herself with weight-loss drugs, two of which are in clinical trials and not yet approved for sale by the US Food and Drug Administration